Trial document




drksid header

  DRKS00009590

Trial Description

start of 1:1-Block title

Title

Survey Preference therapy the urologist who are affected even by a prostate cancer (PCA)

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

PCA - TEPRAEURO

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

The known prevalence and incidence of prostate cancer naturally means that there are numerous self-Affected among practicing urologists. In case of illness, the experience and expertise enrich course considerably and so advising private patients can be strongly influenced. Urological colleagues in Germany will be asked with a questionnaire to describe their own experience and evaluate their actions with regard to diagnosis, treatment strategy and preference.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

There are many therapeutic options to treat prostate cancer and daily says the urologist recommendations to his patients. How a urologist decides a therapy for himself has not been previously described. This questionnaire-based survey is the treatment preference of urology colleagues, which are themselves affected by prostate cancer. A two page questionnaire with three-sided attachment of the German Society of Urology (DGU) is the e-mail distribution sent to all urologist living in Germany. The data collection and analysis and the publication is done anonymously.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00009590
  •   2015/11/04
  •   [---]*
  •   yes
  •   Approved
  •   99/15, Ethikkommission der Medizinischen Fakultät der Otto-von-Guericke-Universität Magdeburg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1175-8700 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   C61 -  Malignant neoplasm of prostate
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   - Sending the questionnaire to all patients about the DGU (German Society of Urology)
    - After a set period of 4 weeks in the cover letter there is a reminder once again via the same distribution ships after 4 weeks.
    - There is a possibility to fill in the PDF-based questionnaire and returned by e-mail or to print it and return it by fax or post. Sends the urologist the questioner sheet by post back is preserved his anonymity.
    - No follow-up.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Treatment
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

The questionnaire is to examine the treatment preference of urology colleagues, which are themselves affected by prostate cancer. The two-page questionnaire with three-sided attachment is sent to all living urologist in Germany via e-mail distribution of the German Society of Urology (DGU). The data collection and analysis and the publication will be descriptive and anonymized.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

/

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2015/11/09
  •   60
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Male
  •   40   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

- Patients ≥40 years
- Disease-specific Men
- Urologists with PCA

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Non

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universitätsklinik für Urologie und Kinderurologie
    • Mr.  Prof. Dr. med.  Martin  Schostak 
    • Leipziger Str. 44
    • 39120  Magdeburg
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • Geschäftsstelle der Deutschen Gesellschaft für Urologie e.V.
    • Uerdinger Str. 64
    • 40474  Düsseldorf
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    •   +49-211-516096-0
    •   +49-211/516096-60
    •   info at dgu.de
    •   [---]*
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • Universitätsklinik für Urologie und Kinderurologie
    • Mr.  OA Dr. med.  Markus  Porsch 
    • Leipziger Str. 44
    • 39120  Magdeburg
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Universitätsklinik für Urologie und Kinderurologie
    • Mr.  OA Dr. med.  Markus  Porsch 
    • Leipziger Str. 44
    • 39120  Magdeburg
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Universitätsklinik für Urologie und Kinderurologie
    • Mr.  Prof. Dr. med.  Martin  Schostak 
    • Leipziger Str. 44
    • 39120  Magdeburg
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2016/09/23
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications


* This entry means the parameter is not applicable or has not been set.